
Clinical
Latest News
Advertisement
Latest Videos

CME Content
Advertisement
More News




















Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.





Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
ICYMI: Highlights From SPD 2025
3
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
4
In CLL, New Therapies Offer Potential for Personalized Approaches
5


















































